LKL International BhdXKLS:0182 -14.29% EBIT per Share is RM-0.07 as of Mar. 2026. The stock has 5 warning signs investors should review. Among 687 Medical Devices & Instruments companies, LKL International Bhd ranks worse than 91.27% on this metric.
LKL International Bhd's EBIT per Share for the
three
months ended in Mar. 2026 was RM-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was RM-0.07.
During the past 3 years, the average EBIT per Share Growth Rate was -33.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for LKL International Bhd's EBIT per Share or its related term are showing as below:
XKLS:0182'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -33.4 Med: -11.4 Max: 52.2
Current: -33.4
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of LKL International Bhd was 52.20% per year. The lowest was -33.40% per year. And the median was -11.40% per year.
XKLS:0182's 3-Year EBIT Growth Rate is ranked worse than 91.27% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs XKLS:0182: -33.40
LKL International Bhd (XKLS:0182) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
LKL International Bhd EBIT per Share Related Terms
LKL International Bhd EBIT per Share Historical Data
* Premium members only.
The historical data trend for LKL International Bhd's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LKL International Bhd (XKLS:0182) has a EBIT per Share of RM-0.07 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on LKL International Bhd and its competitors. According to the industry distribution chart, LKL International Bhd ranks #627 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 91.3%.
Is LKL International Bhd's EBIT per Share too high?
LKL International Bhd's current EBIT per Share is RM-0.07. Based on the distribution chart, LKL International Bhd ranks #627 out of 687 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does LKL International Bhd's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, LKL International Bhd ranks #627 out of 687 companies for EBIT per Share. This places LKL International Bhd in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on LKL International Bhd and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LKL International Bhd's current EBIT per Share is RM-0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.03 — trading 40% below its estimated fair value. The current EBIT per Share is RM-0.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current EBIT per Share is RM-0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0182 has been successfully added to your 